Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants.
Acta Pharm Sin B
; 12(7): 3187-3194, 2022 Jul.
Article
in English
| MEDLINE | ID: covidwho-1676402
ABSTRACT
The heparin polysaccharide nanoparticles block the interaction between heparan sulfate/S protein and inhibit the infection of both wild-type SARS-CoV-2 pseudovirus and the mutated strains through pulmonary delivery.Image 1.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Variants
Language:
English
Journal:
Acta Pharm Sin B
Year:
2022
Document Type:
Article
Affiliation country:
J.apsb.2022.01.019
Similar
MEDLINE
...
LILACS
LIS